Analyst Ratings for Mast Therapeutics (MSTX)

MSTX Rating Summary

  |   Expand Research on MSTX
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 5.7 / 10   Percentile Rank: 60%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
9/27/2016 TD Cowen N/A Downgrade
(Buy)		 N/A
(N/A)		 0.12
(12.42)		 10250% Details
9/21/2016 Maxim Group N/A Downgrade Hold
(Buy)		 N/A
(5.00)		 0.59
(12.42)		 2005.08% Details